Literature DB >> 10350461

Trinitrophenylated reactive lysine residue in myosin detects lever arm movement during the consecutive steps of ATP hydrolysis.

K Ajtai1, Y M Peyser, S Park, T P Burghardt, A Muhlrad.   

Abstract

Trinitrophenylation of the reactive lysine (Lys84) in skeletal myosin subfragment 1 (S1) introduces a chiral probe (TNP) into an interface of the catalytic and lever arm domains of S1 [Muhlrad (1977) Biochim. Biophys. Acta 493, 154-166]. Characteristics of the TNP absorption and circular dichroism (CD) spectra in TNP-modified S1 (TNP-Lys84-S1), and the Lys84 trinitrophenylation rate in native S1, indicate a one-to-one correspondence between ATPase transients and trapped phosphate analogues. Phosphate analogue-induced structures of TNP-Lys84-S1 were modeled using the crystallographic coordinates of S1 [Rayment et al. (1993) Science 261, 50-58] with swivels at Gly699 and Gly710 to approximate conformational changes during ATPase. The CD and absorption spectral characteristics of the model structures were compared to those observed for analogue-induced structures. The model calculations, first tested on a trinitrophenylated hexapeptide with known structure, were applied to TNP-Lys84-S1. They showed that ATP binding initiates swiveling at Gly699 and that swiveling at both Gly710 and Gly699 accompanied ATP splitting just prior to product release. The computed lever arm trajectory during ATPase suggests (i) a plausible mechanism for the nucleotide-induced inhibition of Lys84 trinitrophenylation, and (ii) trinitrophenylation-induced changes in S1 Mg2+- and K+-EDTA ATPase are from collision of the lever arm with TNP at Lys84. TNP is a site-specific structural perturbant of S1 and a chiral reporter group for the effect of Lys84 modification on dynamic S1 structure. As such, TNP-Lys84-S1 is equivalent to a genetically engineered mutant with intrinsic sensitivity to structure local to the modified residue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350461     DOI: 10.1021/bi990149r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Age-related decline in actomyosin structure and function.

Authors:  Ewa Prochniewicz; LaDora V Thompson; David D Thomas
Journal:  Exp Gerontol       Date:  2007-07-05       Impact factor: 4.032

2.  Switch I closure simultaneously promotes strong binding to actin and ADP in smooth muscle myosin.

Authors:  Justin A Decarreau; Nicholas G James; Lynn R Chrin; Christopher L Berger
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

3.  Effect of ionic strength on the conformation of myosin subfragment 1-nucleotide complexes.

Authors:  Y M Peyser; K Ajtai; T P Burghardt; A Muhlrad
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

4.  Solution properties of full length and truncated forms of myosin subfragment 1 from Dictyostelium discoideum.

Authors:  J R Reynoso; A Bobkov; A Muhlrad; E Reisler
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

5.  Myosin dynamics on the millisecond time scale.

Authors:  Thomas P Burghardt; Jimmy Yan Hu; Katalin Ajtai
Journal:  Biophys Chem       Date:  2007-09-11       Impact factor: 2.352

6.  Chemical decoupling of ATPase activation and force production from the contractile cycle in myosin by steric hindrance of lever-arm movement.

Authors:  Andras Muhlrad; Y Michael Peyser; Mahta Nili; Katalin Ajtai; Emil Reisler; Thomas P Burghardt
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

7.  Resolved Structural States of Calmodulin in Regulation of Skeletal Muscle Calcium Release.

Authors:  Megan R McCarthy; Yahor Savich; Razvan L Cornea; David D Thomas
Journal:  Biophys J       Date:  2020-01-21       Impact factor: 4.033

8.  Engineering lysine reactivity as a conformational sensor in the Dictyostelium myosin II motor domain.

Authors:  Mihály Kovács; Judit Tóth; András Málnási-Csizmadia; Clive R Bagshaw; László Nyitray
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.